Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions.
Accumulating evidence indicates that lung cancer arises due to multiple genetic changes in both dominant oncogenes, such as ras, and tumor suppressor genes, such as p53. In this report we examined whether the wild-type p53 gene is able to suppress in vitro and/or in vivo cellular growth of lung cancer cell lines which carry multiple genetic abnormalities. Introduction of a wild-type p53 complementary DNA expression vector into lung cancer cell lines carrying either a homozygous deletion (NCI-H358) or a missense mutation (NCI-H23) in the p53 gene greatly suppressed tumor cell growth. In contrast, p53 expression vectors bearing lung cancer derived mutations affecting single amino acids had lost this growth suppressing ability.
Takahashi
T
T
Laboratory of Chemotherapy, Aichi Cancer Center Research Institute, Nagoya, Japan.
Carbone
D
D
Takahashi
T
T
Nau
M M
MM
Hida
T
T
Linnoila
I
I
Ueda
R
R
Minna
J D
JD
D000818:Animals; D002455:Cell Division; D016158:Genes, p53 / Q000235:genetics / Q000502:physiology*; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology; D051379:Mice; D016513:Mice, SCID; D010957:Plasmids / Q000235:genetics; D014162:Transfection